Urology department MRI use for Prostate Cancer Diagnosis

The request was successful.

Dear The Shrewsbury and Telford Hospital NHS Trust,

Prostate Cancer UK undertook a Freedom of Information Act (FOI) request of all Trusts, Health Boards and Health and Social Care Trusts in 2016, and again in 2018, with the aim of achieving a state of the nation overview of the use of mpMRI before biopsy.

We gained an in-depth understanding of the current status of mpMRI before prostate biopsy across the UK. We have used the data to make the case to National Commissioners for implementation support. It has also guided our funding and development of resources that respond to some of the challenges and barriers to implementation that centres told us they faced.

This third and final round of questions is our means of understanding what progress has been made and to identify where we can target our resources and National Commissioners’ support to have maximum impact.

We really appreciate your help with this. Please pass the below on to your urology department for them to complete. If this is not possible we would really appreciate your help to provide as much information as you can.

Yours faithfully,

Lizzie Ellis

1. Do you routinely conduct prostate MRI (bpMRI/mpMRI) scans before first prostate biopsy as part of the initial diagnostic process? (please tick all that apply):

a. Yes, using T2-weighted, diffusion-weighted (multi-b ADC and high/long b) and dynamic contrast enhanced (DCE) sequences
b. Yes, using T2-weighted, diffusion-weighted (multi-b ADC and high/long b) sequences but not DCE
c. No but we refer to another provider (please provide details)
d. No (please provide details)

2. If yes, to 1a: What percentage of men with suspected prostate cancer receive mpMRI before biopsy as part of the initial diagnostic process?

3. If yes, to 1b: What percentage of men with suspected prostate cancer receive bpMRI before biopsy as part of the initial diagnostic process?

4. What are your eligibility criteria/exclusion criteria for prostate MRI? (please tick all that apply):
a. Age (please provide details)
b. Symptoms (please provide details)
c. Life expectancy (please provide details)
d. Contra-indications (please provide details)
e. Other (please provide details)

5. Are you using results from the prostate MRI before biopsy to rule some men out of biopsy as part of the initial diagnostic process? (yes/no)

6. Do you biopsy all PI-RADS or LIKERT 3 scores?
a. Yes
b. No
c. Dependent on patient histology

7. What threshold do you mostly use for ruling men out of biopsy?
a. PI-RADs 3 and below
b. LIKERT 3 and below
c. PI-RADs 4 and below
d. LIKERT 4 and below
e. Varies depending on age (Please provide detail)
f. Varies depending on other factors (Please provide detail)

8. What percentage of men do you estimate are ruled out of biopsy?

9. Have there been any changes to your prostate MRI capacity in the last year? (please choose all that apply):
a. An additional or new MRI scanner
b. Increased MRI scanner slots for prostate
c. Agreement to use Dynamic Contrast Enhancement
d. No longer using Dynamic Contrast Enhancement
e. A scanner/magnet upgrade
f. other (free text)

10. Has the number of radiologists at your trust/health board who report prostate MRI scans changed in the last year?
a. Increased
b. Decreased
c. Stayed the same

11. How many radiologists at your trust/health board report at least 250 prostate MRI scans per year?

12. Which of the following processes do you follow to manage men ruled out of an immediate biopsy, but with a raised PSA?
a. NICE Guidelines: prostate cancer diagnosis and management (NG131)
b. A local protocol (please provide details)
c. Other (please provide details)

COLE, Sophie (SHREWSBURY AND TELFORD HOSPITAL NHS TRUST), The Shrewsbury and Telford Hospital NHS Trust

3 Attachments

Dear Ms Ellis,

 

Thank you for your request for information.

 

The Trust acknowledges your request and it is being processed as a new
request under the terms of the Freedom of Information Act 2000.

 

In some circumstances a fee may be payable and if that is the case, I will
let you know. A fees notice will be issued to you if necessary and you
will be required to pay before I will proceed to deal with your
request.                                                                            

                                                                  

Please find attached a briefing which explains:

 

o your rights to request a review by the Trust or to complain to the
Information Commissioner’s Office if you are not satisfied with the
response from the Trust,
o an outline of the Trust’s policy on the Reuse of Public Sector
Information

 

If you have any queries regarding this email, please contact me and quote
the reference number above in any future correspondence.

 

 

Kind regards,

Sophie Cole

 

 

 

 

[1]Description: Description: Description: Description: Description:
Description: cid:image001.png@01CF9543.36AA4670

Sophie Cole [4]Description: Description: Description:
Description: Description: Description:
Assurance Team and Freedom of Description: Description:
Information Administrator cid:image001.jpg@01D051EC.FFAC2D70

 

Suite 5, Stretton House|

The Shrewsbury and Telford
Hospital NHS Trust | Royal
Shrewsbury Hospital | Mytton
Oak Road | Shrewsbury |
Shropshire | SY3 8XQ

 

Telephone 01743 261087

Email [2][email address]  

FOI email [3][email address

 

 

 

 

This message may contain confidential information. If you are not the
intended recipient please inform the sender that you have received the
message in error before deleting it. Please do not disclose, copy or
distribute information in this e-mail or take any action in relation to
its contents: to do so is strictly prohibited and may be unlawful.

 

 

 

 

 

 

 

 

 

 

 

show quoted sections

COLE, Sophie (SHREWSBURY AND TELFORD HOSPITAL NHS TRUST), The Shrewsbury and Telford Hospital NHS Trust

3 Attachments

Dear Ms Ellis,

 

Thank you for your FOI request sent on 28^th October 2019. You asked:

 

 

Prostate Cancer UK undertook a Freedom of Information Act (FOI) request of
all Trusts, Health Boards and Health and Social Care Trusts in 2016, and
again in 2018, with the aim of achieving a state of the nation overview of
the use of mpMRI before biopsy.

 

We gained an in-depth understanding of the current status of mpMRI before
prostate biopsy across the UK. We have used the data to make the case to
National Commissioners for implementation support. It has also guided our
funding and development of resources that respond to some of the
challenges and barriers to implementation that centres told us they faced.

 

This third and final round of questions is our means of understanding what
progress has been made and to identify where we can target our resources
and National Commissioners’ support to have maximum impact.

 

We really appreciate your help with this. Please pass the below on to your
urology department for them to complete. If this is not possible we would
really appreciate your help to provide as much information as you can.

 

Yours faithfully,

 

Lizzie Ellis

 

1. Do you routinely conduct prostate MRI (bpMRI/mpMRI) scans before first
prostate biopsy as part of the initial diagnostic process? (please tick
all that apply):

 

a. Yes, using T2-weighted, diffusion-weighted (multi-b ADC and high/long
b) and dynamic contrast enhanced (DCE) sequences b. Yes, using
T2-weighted, diffusion-weighted (multi-b ADC and high/long b) sequences
but not DCE c. No but we refer to another provider (please provide
details) d. No (please provide details)

 

2. If yes, to 1a: What percentage of men with suspected prostate cancer
receive mpMRI before biopsy as part of the initial diagnostic process?

 

3. If yes, to 1b: What percentage of men with suspected prostate cancer
receive bpMRI before biopsy as part of the initial diagnostic process?

 

4. What are your eligibility criteria/exclusion criteria for prostate MRI?
(please tick all that apply):

a. Age (please provide details)

b. Symptoms (please provide details)

c. Life expectancy (please provide details) d. Contra-indications (please
provide details) e. Other (please provide details)

 

5. Are you using results from the prostate MRI before biopsy to rule some
men out of biopsy as part of the initial diagnostic process? (yes/no)

 

6. Do you biopsy all PI-RADS or LIKERT 3 scores?

a. Yes

b. No

c. Dependent on patient histology

 

7. What threshold do you mostly use for ruling men out of biopsy?

a. PI-RADs 3 and below

b. LIKERT 3 and below

c. PI-RADs 4 and below

d. LIKERT 4 and below

e. Varies depending on age (Please provide detail) f. Varies depending on
other factors (Please provide detail)

 

8. What percentage of men do you estimate are ruled out of biopsy?

 

9. Have there been any changes to your prostate MRI capacity in the last
year? (please choose all that apply):

a. An additional or new MRI scanner

b. Increased MRI scanner slots for prostate c. Agreement to use Dynamic
Contrast Enhancement d. No longer using Dynamic Contrast Enhancement e. A
scanner/magnet upgrade f. other (free text)

 

10. Has the number of radiologists at your trust/health board who report
prostate MRI scans changed in the last year?

a. Increased

b. Decreased

c. Stayed the same

 

11. How many radiologists at your trust/health board report at least 250
prostate MRI scans per year?

 

12. Which of the following processes do you follow to manage men ruled out
of an immediate biopsy, but with a raised PSA?

a. NICE Guidelines: prostate cancer diagnosis and management (NG131) b. A
local protocol (please provide details) c. Other (please provide details)

 

 

Under Section 1(1)(a) of the Freedom of Information Act 2000, I can
confirm that The Shrewsbury and Telford Hospital NHS Trust holds
information that falls within the definition in your request which is set
out below:

 

1.Do you routinely conduct prostate MRI (bpMRI/mpMRI) scans before first
prostate biopsy as part of the initial diagnostic process? (please tick
all that apply):

Yes

 

b. Yes, using T2-weighted, diffusion-weighted (multi-b ADC and high/long
b) sequences but not DCE

 

2. If yes, to 1a: What percentage of men with suspected prostate cancer
receive mpMRI before biopsy as part of the initial diagnostic process? We
do not have this data recorded

 

3. If yes, to 1b: What percentage of men with suspected prostate cancer
receive bpMRI before biopsy as part of the initial diagnostic process? We
do not have this data recorded

 

4. What are your eligibility criteria/exclusion criteria for prostate MRI?
(please tick all that apply):

a. Age (please provide details) below 75

b. Symptoms (please provide details) No

c. Life expectancy (please provide details) No

d. Contra-indications (please provide details)  No

e. Other (please provide details)

 

5. Are you using results from the prostate MRI before biopsy to rule some
men out of biopsy as part of the initial diagnostic process? (yes/no) Yes

 

6. Do you biopsy all PI-RADS or LIKERT 3 scores?

a. Yes

b. No

c. Dependent on patient histology

We don’t use Pi-RADS

 

7. What threshold do you mostly use for ruling men out of biopsy?

a. PI-RADs 3 and below

b. LIKERT 3 and below

c. PI-RADs 4 and below

d. LIKERT 4 and below

e. Varies depending on age (Please provide detail) f. Varies depending on
other factors (Please provide detail)

MRI report

 

8. What percentage of men do you estimate are ruled out of biopsy?

We do not have this data recorded

 

9. Have there been any changes to your prostate MRI capacity in the last
year? (please choose all that apply):

b. Increased MRI scanner slots for prostate

 

10. Has the number of radiologists at your trust/health board who report
prostate MRI scans changed in the last year?

c. Stayed the same

 

11. How many radiologists at your trust/health board report at least 250
prostate MRI scans per year?

One

 

12. Which of the following processes do you follow to manage men ruled out
of an immediate biopsy, but with a raised PSA?

a. NICE Guidelines: prostate cancer diagnosis and management (NG131)

 

Please also find attached a briefing which explains your rights to request
a review by the Trust or to complain to the Information Commissioner’s
Office if you are not satisfied with the response from the Trust, and an
outline of the Trust’s policy on the Reuse of Public Sector Information.

 

If you have any queries regarding this email, please contact the Freedom
of Information Officer via [1][The Shrewsbury and Telford Hospital NHS Trust request email] and quote the reference
number above in any future correspondence. If you would like to give
feedback please visit [2]https://www.surveymonkey.co.uk/r/DXTP8QQ for our
short questionnaire.

 

Kind regards,

Sophie Cole

 

[3]Description: Description: Description: Description: Description:
Description: cid:image001.png@01CF9543.36AA4670

Sophie Cole [6]Description: Description: Description:
Description: Description: Description:
Assurance Team and Freedom of Description: Description:
Information Administrator cid:image001.jpg@01D051EC.FFAC2D70

 

Suite 2, Stretton House|

The Shrewsbury and Telford
Hospital NHS Trust | Royal
Shrewsbury Hospital | Mytton
Oak Road | Shrewsbury |
Shropshire | SY3 8XQ

 

Telephone 01743 261087

Email [4][email address]  

FOI email [5][email address

 

 

 

 

This message may contain confidential information. If you are not the
intended recipient please inform the sender that you have received the
message in error before deleting it. Please do not disclose, copy or
distribute information in this e-mail or take any action in relation to
its contents: to do so is strictly prohibited and may be unlawful.

 

 

 

 

 

 

 

show quoted sections